# Evaluation of pyroptosis-associated genes in endometrial cancer utilizing a 101-combination machine learning framework and multi-omics data

**Authors:** Li Juan Huang, Chen Liu, Lin Chen, Min Tang, Shi Tong Zhan, Feng Chen, An Yi Teng, Li Na Zhou, Wei Lin Sang, Ye Yang

PMC · DOI: 10.3389/fmed.2025.1590405 · Frontiers in Medicine · 2025-06-05

## TL;DR

This study explores how pyroptosis-related genes affect endometrial cancer prognosis and immune response, using machine learning and multi-omics data to build a predictive model.

## Contribution

A novel 101-combination machine learning framework and multi-omics approach to identify pyroptosis-associated genes in endometrial cancer.

## Key findings

- A seven-gene model predicted patient outcomes with a C-index over 0.70 in training and validation sets.
- High- and low-risk groups showed distinct immune infiltration profiles and PD-1 blockade responses.
- Drug sensitivity analysis identified potential therapies for high- and low-risk subgroups.

## Abstract

Endometrial cancer (EC) is a common and increasingly prevalent gynecological malignancy. Pyroptosis, a pro-inflammatory form of programmed cell death, plays dual roles in cancer but remains poorly understood in the context of EC and its immune microenvironment.

We identified pyroptosis-associated genes (PAGs) and applied a 101-combination machine learning framework to construct and validate a robust prognostic model using TCGA bulk RNA-seq and single-cell transcriptomic data. Immune infiltration was assessed using CIBERSORT and Tumor Immune Dysfunction and Exclusion (TIDE), while CellChat was employed to investigate pyroptosis-related cell–cell communication. Drug sensitivity was predicted with OncoPredict.

A seven-gene prognostic model demonstrated robust predictive performance with concordance index (C-index) values exceeding 0.70 in both training and validation cohorts. The model stratified EC patients into high- and low-risk groups with distinct immune infiltration profiles and differential responses to programmed cell death protein 1 (PD-1) blockade. Drug sensitivity analysis revealed several therapeutic agents with potential efficacy in high-risk and low-risk subgroups.

This study highlights the clinical and immunological relevance of pyroptosis in EC and introduces a PAG-based model with strong predictive and therapeutic potential. These findings provide a foundation for developing pyroptosis-guided precision immunotherapy strategies in EC.

## Linked entities

- **Proteins:** PDCD1 (programmed cell death 1)
- **Diseases:** endometrial cancer (MONDO:0002447)

## Full-text entities

- **Genes:** PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}
- **Diseases:** inflammatory (MESH:D007249), gynecological malignancy (MESH:D005833), cancer (MESH:D009369), EC (MESH:D016889), Tumor Immune Dysfunction (MESH:D007154)
- **Chemicals:** PAG (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12176823/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12176823/full.md

## References

66 references — full list in the complete paper: https://tomesphere.com/paper/PMC12176823/full.md

---
Source: https://tomesphere.com/paper/PMC12176823